Q1 2019 Biosyent Inc Earnings Call Transcript
© -
Hello, and welcome to the BioSyent Q1 2019 results presentation. My name is René Goehrum, and I'm the President and CEO of the company.
I'll draw your attention to our disclaimer on forward-looking statements and start the presentation with a look at our sales, EBITDA and net income after tax for the first quarter.
So to draw your attention to the right side of the screen, you can see our sales overall were up 1% versus year ago, our EBITDA down 19% and our net income after tax down 14% when compared to year ago. So a couple of comments generally on profitability and on revenue. So this quarter represented our 35th consecutive profitable quarter. So for those keeping score, that's almost 9 years.
Our Pharma business in Canada is strong, showed 13% growth measured in dollars in the first quarter versus year ago. Our International Pharma business has got an unusual number there. It's minus 100%. So in the quarter, we didn't ship any orders to customers for our International Pharma business. And I've got
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
